Cost and clinical consequence of antibiotic non-adherence in acute exacerbations of chronic bronchitis.

Sorensen, S. V., Baker, T., Fleurence, R., Dixon, J., Roberts, C., Haider, S. & Hughes, D., 1 Aug 2009, In: International Journal of Tuberculosis and Lung Disease. 13, 8, p. 945-954

Research output: Contribution to journal › Article › peer-review

Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout

Plumpton, C., Alfirevic, A., Pirmohamed, M. & Hughes, D., 1 Oct 2017, In: Rheumatology. 56, 10, p. 1729-1739

Research output: Contribution to journal › Article › peer-review

Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy

Plumpton, C. O., Yip, V., Alfirevic, A., Marson, A., Pirmohamed, M. & Hughes, D., Nov 2013, In: Value in Health. 16, 7, p. A624-A624

Research output: Contribution to journal › Article › peer-review

Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT)

Russell, I. T., Orford, J., Alwyn, T., Black, R., Copello, A., Coulton, S., Farrin, A., Godfrey, C., Morton, V., Finnegan, O., Handforth, L., Middleton, W., Raistrick, D., Thistlethwaite, G., Tober, G., Westwood, A., Fryer, K., Heather, N., Hodgson, R., John, B., Kerr, C., Parrott, S., Slegg, G. & Smith, M., 10 Sept 2005, In: British Medical Journal. 331, 7516, p. 544-548

Research output: Contribution to journal › Article › peer-review

Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease

Hughes, D. & Hughes, D. A., 1 Nov 2004, In: Value in Health. 7, 6, p. 753

Research output: Contribution to journal › Article › peer-review

Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

Hughes, D., Hughes, D. A., Marchetti, M. & Colombo, G., 1 Feb 2005, In: Expert Review of Pharmacoeconomics and Outcomes Research. 5, 1, p. 29-38

Research output: Contribution to journal › Article › peer-review

Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

Hughes, D., Pink, J., Pirmohamed, M., Lane, S. & Hughes, D. A., 23 Sept 2013, In: Clinical Pharmacology and Therapeutics.

Research output: Contribution to journal › Article › peer-review

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Jun 2004, In: Pharmacogenetics. 14, 6, p. 335-342

Research output: Contribution to journal › Article › peer-review

Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

Hughes, D., Hughes, D. A. & Dubois, D., 1 Jan 2004, In: Pharmacoeconomics. 22, 16, p. 1047-1059

Research output: Contribution to journal › Article › peer-review

Cost-effectiveness findings from the Agewell pilot study of behaviour change to promote health and wellbeing in later life

Jones, C. L., Edwards, R. T., Nelis, S. M., Jones, I. R., Hindle, J. V., Thom, J. M., Cooney, J. & Clare, L., 8 Dec 2015, In: Health Economics and Outcome Research: Open Access. 1, 1

Research output: Contribution to journal › Article › peer-review